Fluxion Denies IP Infringement Claims Made by Cellectricon | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (Genomeweb News) – Fluxion Biosciences today has denied that it is infringing patents held by Cellectricon that are at the center of an IP infringement suit that initially began in July 2009 but resumed this week.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.